Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Intellectual disability; and common findings: Macrocephaly. 3 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 2 | Delayed speech and language development, Intellectual disability |
Biomarker and diagnostic research for chromosome Xp11.22 duplication syndrome has been reported in the published literature.
Phenotype severity distribution: 1 always present feature, 1 common feature.
No clinical trials have been registered for chromosome Xp11.22 duplication syndrome.
200 publications have been identified in PubMed for chromosome Xp11.22 duplication syndrome. Kisho has analyzed 74 by research type. Research spans Review / Meta-Analysis (49%), Epidemiology / Natural History (16%), and Basic Science / Preclinical (15%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 36 | 49% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 2:57 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Common questions about chromosome Xp11.22 duplication syndrome
1 |
Macrocephaly |
Disease patterns and progression |
12 |
16% |
Laboratory research | 11 | 15% |
Patient case studies | 8 | 11% |
Testing and diagnosis research | 5 | 7% |
Other research | 1 | 1% |
Clinical study results | 1 | 1% |
Barrington M (2026). [PMID: 41846499](https://pubmed.ncbi.nlm.nih.gov/41846499/). *Health expectations : an international journal of public participation in health care and health policy*. [Review / Meta-Analysis]
Ye X (2026). [PMID: 41562601](https://pubmed.ncbi.nlm.nih.gov/41562601/). *J Intellect Disabil Res*. [Epidemiology / Natural History]
Choi YK (2026). [PMID: 41172359](https://pubmed.ncbi.nlm.nih.gov/41172359/). *Australas Psychiatry*. [Other]
Jiao Y (2026). [PMID: 41443536](https://pubmed.ncbi.nlm.nih.gov/41443536/). *J Genet Genomics*. [Basic Science / Preclinical]
Ülker Üstebay D (2026). [PMID: 42181738](https://pubmed.ncbi.nlm.nih.gov/42181738/). *Hum Mutat*. [Case Report / Case Series]
Archer J (2026). [PMID: 40874586](https://pubmed.ncbi.nlm.nih.gov/40874586/). *Clin Genet*. [Case Report / Case Series]
Barrington M (2026). [PMID: 39939836](https://pubmed.ncbi.nlm.nih.gov/39939836/). *Scandinavian journal of public health*. [Review / Meta-Analysis]
Lo HWJ (2025). [PMID: 39874647](https://pubmed.ncbi.nlm.nih.gov/39874647/). *Midwifery*. [Review / Meta-Analysis]
Noordhuis-Zijderveld A (2025). [PMID: 40484370](https://pubmed.ncbi.nlm.nih.gov/40484370/). *Eur J Med Genet*. [Epidemiology / Natural History]
Grennan C (2025). [PMID: 41043239](https://pubmed.ncbi.nlm.nih.gov/41043239/). *Epilepsy Behav*. [Epidemiology / Natural History]